REPAGLINIDE BEKER®

RepaGlinide BEKER ® is an oral diabetes medicine, indicated for the treatment of Type 2 diabetes, when high blood sugar can no longer be satisfactorily controlled through diet, exercise and weight loss. Repaglinide is also indicated in combination with metformin in adult type 2 diabetics who are not satisfactorily balanced with metformin alone.

Additional information

DCI

REPAGLINIDE

Dosage

0,5 mg

Trade name

REPAGLINIDE BEKER®

Name of the originator

Novoform

Presentation

30 tablets

Specialty

Métabolisme – ADO

See also